Brief: Dynavax Announces Convertible Debt Refinancing
06/03/2025 12:28
March 6 (Reuters) - Dynavax Technologies DVAX.O: DYNAVAX ANNOUNCES CONVERTIBLE DEBT REFINANCING AND COMMON STOCK SHARE REPURCHASE DYNAVAX TECHNOLOGIES CORP - ISSUES $225 MILLION OF CONVERTIBLE NOTES DUE 2030 DYNAVAX TECHNOLOGIES CORP: DYNAVAX REPURCHASED $8 MILLION OF CO'S COMMON STOCK IN CONNECTION WITH THIS TRANSACTION DYNAVAX TECHNOLOGIES CORP - NEW NOTES CONVERSION PRICE INITIALLY $18.21 PER SHARE DYNAVAX TECHNOLOGIES CORP - EXPECTS TO RECEIVE $46.5 MILLION FROM UNWIND TRANSACTIONS Source text: ID:nPn9lGwfxa Further company coverage: DVAX.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Dynavax Technologies
See all newsNASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM
OneSpaWorld jumps as co poised to join S&P SmallCap index
Sanofi targets high single digit sales growth in 2026, plans share buyback (updated)
Focus: Vaccine makers feel a chill as US Health Secretary Kennedy's rhetoric becomes reality